Insider: Robb Gary Charles Chief Business Officer - CORCEPT THERAPEUTICS INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 16,038 | 0 | 16,038 |
| Value | $1,340,215.47 | $0.00 | $1,340,215.47 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 08/22/2025 | DDS | 2,326 | Direct | COM | $71.27 | $165,774.02 | 16,038 |
| 06/16/2025 | DDS | 3,185 | Direct | COM | $70.77 | $225,402.45 | 13,364 |
| 05/20/2025 | DDS | 2,279 | Direct | COM | $75.85 | $172,862.15 | 16,586 |
| 01/02/2025 | DDS | 11,000 | Direct | COM | $50.50 | $555,551.70 | 20,119 |
| 11/22/2024 | DDS | 2,609 | Direct | COM | $56.20 | $146,625.80 | 20,163 |
| 08/26/2024 | DDS | 3,101 | Direct | COM | $35.71 | $110,736.71 | 23,190 |
| 07/01/2024 | DDS | 11,000 | Direct | COM | $32.49 | $357,390.00 | 26,291 |
| 05/28/2024 | DDS | 11,000 | Direct | COM | $30.39 | $334,294.40 | 20,203 |
| 12/06/2023 | DDS | 6,212 | Direct | COM | $27.01 | $167,786.12 | 21,390 |
| 12/05/2023 | DDS | 1,381 | Direct | COM | $26.27 | $36,277.21 | 27,602 |
| 09/19/2023 | DDS | 5,000 | Direct | COM | $32.74 | $163,677.00 | 21,996 |
| 05/10/2023 | DDS | 14,000 | Direct | COM | $24.07 | $336,980.00 | 19,997 |
| 05/09/2023 | DDS | 30,000 | Direct | COM | $23.87 | $716,100.00 | 33,997 |
| 11/23/2022 | DDS | 186 | Direct | COM | $26.03 | $4,841.58 | 21,143 |
| 11/22/2022 | DDS | 4,814 | Direct | COM | $26.03 | $125,308.42 | 21,329 |
| 11/18/2022 | DDS | 13,401 | Direct | COM | $26.43 | $354,188.43 | 26,143 |
| 11/17/2022 | DDS | 10,000 | Direct | COM | $26.06 | $260,600.00 | 39,544 |
| 09/07/2022 | DDS | 50,000 | Direct | COM | $26.06 | $1,303,000.00 | 49,544 |
| 07/06/2022 | DDS | 45,000 | Direct | COM | $26.00 | $1,170,000.00 | 24,123 |
| 05/19/2022 | DDS | 6,127 | Direct | COM | $19.57 | $119,928.06 | 36,446 |
| 05/18/2022 | DDS | 128 | Direct | COM | $19.55 | $2,502.40 | 42,573 |
| 05/17/2022 | DDS | 28,745 | Direct | COM | $19.55 | $561,964.75 | 42,701 |
| 03/18/2022 | DDS | 4,988 | Direct | COM | $24.67 | $123,053.96 | 71,446 |
| 03/17/2022 | DDS | 7,512 | Direct | COM | $24.68 | $185,374.38 | 76,434 |
| 09/15/2021 | DDS | 47,853 | Direct | COM | $20.49 | $980,742.45 | 87,848 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research